International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net

ORIGINAL RESEARCH ARTICLE
Int J Pharm Bio Sci Volume 5 Issue 4, 2014 (October - December), Pages:119-125

EVALUATION OF ANTITUMOR PROPERTIES OF RHIZOME OF ACORUS CALAMUS L USING DALTON'S ASCITES LYMPHOMA BEARING SWISS ALBINO MICE.

 

SREEJAYA, S.B. AND SANTHY, K.S
DOI:
Abstract:

Herbal concoctions have recently been investigated for various chronic and complicated ailments as effective therapeutics. The Ayurvedic literature of India is essentially focussed for their biologically active constituents in whole for efficacy. In this study, a preliminary analysis of the rhizomes of Acorus calamus L, has been investigated as a potent antitumour agent against Daltons Ascites Lymphoma in mice by evaluating the tumour growth, toxicity and haematological parameters. The methanolic extract of Acorus calamus (MEAC) was observed to restore the hematological parameters as compared with the DAL bearing mice in a dose dependant manner indicating a significant antitumour activity, thus indicating A. calamus to be a potent ethnomedicine.

Keywords: Acorus calamus, Daltons ascites lymphoma, methanol, extract, rhizome.
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© 2009-2026 IJPBS, India. All rights reserved. Specialized online journals by ubijournal | Home | Contact | Terms & Conditions